Archive for dairy genetics market

GENETIC GIANTS DETHRONED: How Dairy Farmers and Beef Upstarts Hijacked 75% of the Beef-on-Dairy Gold Rush

Traditional genetics companies are caught sleeping while dairy farmers and beef upstarts steal 75% of the booming beef-on-dairy market. Who’s winning?

The titans of dairy genetics have been caught with their pants down, and they’re scrambling to cover up as a new breed of competitors eats their lunch. While most of the big dairy genetics companies were busy selling premium dairy semen and collecting awards for high TPI bulls, an entirely new market emerged right under their noses. Today, beef-on-dairy inseminations represent a staggering portion of the US market, with traditional genetics companies controlling only about 25% of this booming segment. The real winners? It was a scrappy collection of non-traditional players who saw an opportunity while the industry giants were asleep at the wheel. This massive market disruption has forced established dairy genetics providers  into multiple layoffs as they desperately try to adapt to a shifting landscape beneath their feet.

The Market Upheaval Traditional Companies Never Saw Coming

Let’s be brutally honest: the established genetics companies missed the boat. They spent decades perfecting their dairy genetic evaluation systems, building elaborate genomic indexes, and commanding premium prices while assuming their market dominance was untouchable. Meanwhile, innovative dairy producers and beef-focused upstarts quietly created a parallel genetic supply chain to capture three-quarters of the explosive beef-on-dairy market.

The shift happened with breathtaking speed. According to peer-reviewed research published in January 2023, the contribution of dairy steers to the U.S.-fed beef supply has increased from 6.9% to 16.3% over the last two decades. This dramatic rise is attributed partly to declining beef cow numbers and the increased use of sexed dairy semen to produce genetically superior replacement heifers from the best dairy cows. What was once a secondary market has become the primary breeding strategy for millions of dairy cows.

The economic drivers behind this transformation are clear. In 2016, Holstein bull calves had almost no value, and significant U.S. beef packers actively rejected Holstein-fed animals. Facing this economic reality, dairy farmers were forced to seek alternatives – beef semen provided the perfect solution.

The New Breed of Genetic Providers

While the genetics establishment was busy calculating genomic indexes and marketing premium dairy sires, a diverse group of entrepreneurs seized the beef-on-dairy opportunity.

Grimmius Cattle Company: From Cattle Feeder to Genetic Powerhouse

Once known primarily as a cattle-feeding operation that handled dairy steers and heifers since the 1960s, Grimmius has transformed itself into a genetic force by aggressively acquiring premium Angus genetics. Their strategy? Purchase high-selling bulls from elite breeders, including Hoover Angus Farm, Spring Cove Ranch, and Gardner Angus Ranch. Rather than trying to build a genomic program from scratch, they’ve gone straight to proven genetics that delivers in the feedlot—something they understand better than most dairy-focused genetic companies ever could.

Dairy Producers Turn Genetics Suppliers

The boldest move in this market revolution comes from giant dairy operations like Riverview and Faria that have completely bypassed traditional genetics providers. With thousands of cows under management, these operations have determined it’s more economical to develop their semen production facilities than to purchase from established companies.

Faria now produces all its beef semen, leveraging its massive scale to justify the investment in collection facilities and bull maintenance. The economics are simple and devastating for traditional dairy genetics providers: at a sufficient scale, in-house production eliminates markup, allows customized genetic selection, and creates potential for additional revenue by selling excess inventory to neighboring operations.

The Economic Bloodbath for Traditional Companies

The financial consequences for established genetics companies have been severe and are getting worse. As beef-on-dairy breeding has exploded, the market for conventional dairy semen has contracted significantly. This market evaporation coincided with inflationary pressures that increased operational costs.

The math doesn’t work for companies structured around high-volume sales with substantial overhead. Their business model was built around a specific blend of sales and volumes that the beef-on-dairy revolution has wholly undermined.

The brutal reality? Traditional genetics companies now face higher per-unit costs for dairy semen production because their fixed expenses must be spread across fewer units sold. Meanwhile, their beef programs lack the specialized expertise and market connections that give focused beef genetics providers their competitive edge.

The Fundamental Disconnect Fueling the Revolution

This market transformation is fascinating because of the vast disconnect between dairy and beef producers’ evaluation of genetic merit. Dairy producers have traditionally selected which cows to breed to beef based primarily on reproductive performance, lactation number, and milk production.

For many producers, the criteria for selecting beef semen are remarkably straightforward: cost, conception rate, calving ease, and solid black hair coat. This “black calf syndrome” represents both a market failure and an enormous opportunity.

Many dairy producers don’t fully appreciate the significant differences between dairy and beef cattle carcasses. Scientific research shows that dairy steers have lower dressing percentages and yield 2%—12% less red meat than beef steers due to a better ratio of bone to muscle, internal fat, organ size, and gastrointestinal tract weight. Also, Holstein carcasses are more extended, while Jersey carcasses are typically lighter than beef breeds.

Does this create unique challenges in the beef packing industry? Well-designed beef × dairy crossbreeding strategies can address these. Well-designed crossbreeding can improve feed efficiency (gain-to-feed ratio) and red meat yield from dairy-origin animals.

The Angus Association attempted to address this by developing specific indexes for beef-on-dairy. In contrast, a joint venture between the Holstein Association USA and the American Simmental Association has developed the HOLSim index for selecting Simmental, and Angus crossed bulls for use on Holstein females. These indexes emphasize calving ease, marbling, muscle conformation, and appropriate carcass length.

However, adoption has been limited as “dairy people don’t think like beef people.” This fundamental disconnect creates inefficiencies and opportunities for providers who can bridge this knowledge gap.

The Future Belongs to the Specialists

The genetics marketplace is undergoing a fundamental restructuring that traditional companies cannot ignore. Most beef-on-dairy crosses reported use Angus semen, demonstrating how concentrated this market has become.

For traditional genetics companies to survive, they must either dramatically downsize their operations or develop specialized beef genetics divisions that can compete with focused providers. Major genetics companies have already moved in this direction by expanding their beef operations, but they’re playing catch-up in a market where specialist providers have established significant advantages.

Meanwhile, innovative dairy producers will continue moving toward vertical integration for their dairy and beef genetics supply. The economics are too compelling to ignore – why pay premium prices for genetics when you can produce custom-tailored semen in-house at a fraction of the cost?

The opportunity is enormous for specialized beef genetics providers. By focusing exclusively on the beef-on-dairy segment and developing products optimized for this specific market niche, they can deliver superior economic outcomes compared to generic “black calf” programs. The real innovation will come from providers bringing dairy-style genomic evaluation to beef-on-dairy breeding decisions.

Understanding the Economics: Dairy vs. Beef Carcass Differences

CharacteristicDairy SteersBeef SteersPotential Improvement with Optimized Beef × Dairy Breeding
Dressing PercentageLowerHigher2-5% improvement
Red Meat Yield2-12% lessBaseline3-8% improvement
Carcass LengthLonger (Holstein)StandardCan be addressed with proper sire selection
Carcass WeightLighter (Jersey)StandardCan be addressed with proper sire selection
Quality GradeMore desirable on averageVariableMaintains advantage with proper genetics
Performance PredictabilityHigh uniformityMore variableMaintains advantage with proper genetics

Source: Based on peer-reviewed research published January 2023

Looking Ahead: Winners and Losers in the New Genetics Landscape

As this market transformation accelerates, clear winners and losers are emerging. The winners? Nimble, specialized beef genetics providers who understand both dairy production systems and beef quality requirements. These providers are both large dairy operations with sufficient scale to justify in-house semen production and innovative crossbreed specialists who can optimize results for both dairy and beef traits.

The losers are traditional genetics companies that fail to adapt quickly enough. The market share they’ve already lost is likely gone forever—the only question is whether they can stabilize their position or continue losing ground.

This transformation creates both opportunities and challenges for dairy producers. The proliferation of genetic sources provides more options but requires a more sophisticated evaluation of potential partners. Those who approach beef-on-dairy breeding with the same analytical rigor they apply to their dairy breeding program will capture significantly more value than those settling for commodity black calves.

5 Questions Dairy Farmers Should Ask When Evaluating Beef Genetics Providers

  1. Beyond black hide and calving ease, what specific genetic traits does your program select that will maximize my calves’ value in the beef chain?
  2. What data can you provide on feedlot performance and carcass characteristics of your sires’ progeny?
  3. When selecting bulls, do you use specific beef-on-dairy indexes like $AxH or HOLSim?
  4. What price premiums are your beef-on-dairy calves averaging compared to generic black calves?

Can you provide references from dairy producers who’ve seen measurable economic benefits from using your genetics?

Conclusion: The Revolution is Permanent

The beef-on-dairy revolution has permanently altered the genetics landscape. What was once a market dominated by a handful of large genetics companies has transformed into a diverse ecosystem where specialized providers and vertically integrated dairy operations play increasingly important roles.

The established genetic providers have been caught flat-footed by this transformation. While they’ve begun adjusting their strategies, the question remains whether they can adapt quickly enough to capture market share from the upstarts who first recognized this opportunity.

For The Bullvine readers, the message is clear: the genetic marketplace is more competitive and diverse than ever before. Whether you’re a large-scale operator considering vertical integration or a medium-sized producer evaluating breeding options, the days of defaulting to traditional genetics providers are likely over. The genetics industry has been disrupted, and innovative producers will leverage this disruption to capture more value from every breeding decision.

Key Takeaways

  • Beef-on-dairy has grown dramatically, with dairy steers increasing from 6.9% to 16.3% of the U.S.-fed beef supply over two decades.
  • Traditional genetics companies were caught unprepared for this market shift and now control only a minority share of the beef-on-dairy market.
  • Large-scale dairy operations like Riverview and Faria have vertically integrated by producing their beef semen, bypassing traditional providers entirely.
  • Many dairy producers select beef sires based primarily on simple criteria (black coat, calving ease) rather than comprehensive genetic merit that would maximize calf value.
  • Asking targeted questions about specific genetic traits, feedlot performance data, and specialized beef-on-dairy indexes can help producers capture significantly more value from crossbreeding programs.

Executive Summary

The dairy genetics industry is experiencing a seismic shift as beef-on-dairy breeding has exploded to approximately 40% of all dairy inseminations. Still, surprisingly, traditional genetics companies control only about 25% of this rapidly growing segment. While established players focused on high-value dairy genetics, innovative dairy operations and specialized beef providers recognized the opportunity and created alternative supply chains that now dominate the market. This transformation has permanently altered the competitive landscape, with large dairy operations developing semen production capabilities and specialized beef genetics providers delivering targeted solutions. This disruption means more options for dairy producers but requires more sophisticated evaluation when selecting genetic partners to maximize the value of beef-on-dairy crossbred calves.


Download “The Ultimate Dairy Breeders Guide to Beef on Dairy Integration” Now!

Are you eager to discover the benefits of integrating beef genetics into your dairy herd? “The Ultimate Dairy Breeders Guide to Beef on Dairy Integration” is your key to enhancing productivity and profitability. This guide is explicitly designed for progressive dairy breeders, from choosing the best beef breeds for dairy integration to advanced genetic selection tips. Get practical management practices to elevate your breeding program. Understand the use of proven beef sires, from selection to offspring performance. Gain actionable insights through expert advice and real-world case studies. Learn about marketing, financial planning, and market assessment to maximize profitability. Dive into the world of beef-on-dairy integration. Leverage the latest genetic tools and technologies to enhance your livestock quality. By the end of this guide, you’ll make informed decisions, boost farm efficiency, and effectively diversify your business. Embark on this journey with us and unlock the full potential of your dairy herd with beef-on-dairy integration. Get Started!

Learn more

Join the Revolution!

Join over 30,000 successful dairy professionals who rely on Bullvine Daily for their competitive edge. Delivered directly to your inbox each week, our exclusive industry insights help you make smarter decisions while saving precious hours every week. Never miss critical updates on milk production trends, breakthrough technologies, and profit-boosting strategies that top producers are already implementing. Subscribe now to transform your dairy operation’s efficiency and profitability—your future success is just one click away.

NewsSubscribe
First
Last
Consent

ABS Acquires De Novo: Strategic Move for Sale or Survival?

Why did ABS buy De Novo? Is it a survival tactic or part of a bigger plan? Find out more.

The recent purchase of De Novo by ABS has sent waves across the dairy farming business. For those who study trends, this shift presents a critical question: Is this a deliberate move for future expansion or an indication that ABS is preparing for a sale? The stakes are high, and the consequences are significant. This is not simply another commercial deal; it can change the competitive environment. But what does this entail for the stakeholders? Everyone believes they are broke, particularly after the significant staff cuts earlier this year. However, purchases like De Novo may signal that something far more significant is at work.

The timing and circumstances of this transaction raise several questions. On the one hand, it might represent ABS’s effort to strengthen its genetics portfolio and stay competitive in a changing industry. On the other hand, it may be arranging itself nicely for sale, presenting all its assets in a clean, enticing package. This could benefit stakeholders significantly, offering them a brighter future in the industry.

To understand the full scope, let’s break down the components: 

  • Consolidation of intellectual property.
  • Potential market strategy shifts.
  • Industry rumors and speculations.

As we explore these aspects more, it’s crucial to consider what this implies for you and your company. Is ABS laying the groundwork for innovation, or are they prepared to transfer the baton? Understanding these implications is vital for your company’s future decisions and strategies.

What’s the Real Strategy Behind ABS Global’s Recent Moves and What Could They Mean for Stakeholders and Potential Investors

ABS Global, a subsidiary of UK-based Genus PLC, has recently been navigating turbulent seas. Earlier this year, the corporation cut off many of its personnel, stoking speculation of financial difficulties. Industry insiders have speculated if ABS is on the verge of collapse. However, the current purchase has provided an exciting twist to the narrative.

Genus PLC, recognized for its diverse interests in swine genetics and biotechnology, has long sought to increase pig production efficiency. Their significant efforts in swine research have resulted in improved, more inexpensive protein production—a vital need in today’s global market. This strategy shift has fueled speculation that Genus may emphasize its successful swine business and sell off its meat and dairy divisions. Enter the chatter about Chinese purchasers.

Why is China interested in ABS’ swine technology? The solution is found in the need for protein and cost efficiency. China’s enormous population is constantly struggling to create enough inexpensive protein. ABS’s superior swine technology may be the answer, enabling Chinese farmers to modify pig genetics for increased protein production easily. This technology isn’t just about satisfying immediate requirements; it’s also about future-proofing against rising demand as China’s middle class grows.

If the reports are accurate, savvy investors may see a jackpot. Genus intends to unload these areas to concentrate on swine technology. With China’s booming market in mind, these assets would be stunning. Furthermore, some believe ABS’s recent layoffs and strategic purchases are preparation actions. These actions make ABS a more appealing investment or connect more closely with Genus’ swine-focused objectives.

Who Could Be Eyeing ABS Global Next? The Strategic Arms Race Between URUS and STgen

Regarding prospective ABS purchasers, two names stand out: URUS and STgen. Both have different objectives and strategic goals that profit significantly from the purchase.

URUS: This corporation, already a dairy and cattle genetics industry behemoth, has lately made significant financial advances. They received support from UK bankers CVC, indicating they are preparing for something huge. Could they be planning to buy ABS? Is this consistent with their “complete solution” approach? URUS is now dominant in genetics but underrepresented in feed and nutrition. Adding ABS to their portfolio may bring the same advantages as expanding into feed and nutrition sectors, providing a full range of services to dairy producers and growing market share.

STgen, on the other hand, has acquired a sizable fortune from its intellectual property in sexed semen. It has been a market leader in that segment. Interestingly, ABS already has a sexed semen product, so this may seem paradoxical. However, the purchase may exacerbate STgen’s monopolistic fears. At the same time, the company awaits the US government’s judgment on its merger with Select Sires. Owning ABS might lead to severe antitrust difficulties.

The Critical Question: Can ABS Global Regain Its Former Glory?

ABS Global’s market dominance waned during the 2000s, which is no secret. ABS was once a dominant force in the dairy business in the United States. Still, substantial reductions have been seen in recent years. This raises the question: where does ABS fit today?

ABS Global has taken exact steps to recover some control. They have been active in their pursuit of intellectual property. Why is this important? In today’s market, having complete control over product creation is critical. Companies such as Alta Genetics with their Peak program, STgen with their program, and Select Sires and Semex with their separate programs share one feature: They have complete control over their female programs from beginning to end.

So, what does this imply for ABS? This approach allows ABS to control its product development entirely, making it more appealing to prospective customers. This is especially important if they want to sell. Demonstrating ownership and control over manufacturing is a significant selling factor.

ABS’s recent purchase of De Novo supports this plan. Initially, the agreement was pricey, securing Desu’s genetic influence. However, owning De Novo removes expensive royalties and enables ABS to incorporate this intellectual property into its business fully. It’s more than simply a cost-cutting measure; it’s a deliberate move to improve their market share.

While ABS may no longer have the clout, it once had in the 2000s, its purchase of intellectual property and efforts to regain total control over product development are deliberate steps toward reclaiming its industry relevance. This potential for resurgence makes ABS an intriguing player, sparking interest in its future trajectory.

Looking Ahead: What Does the Acquisition of De Novo Imply for ABS Global’s Future? 

Looking forward, the purchase of De Novo represents a major strategic shift for ABS Global. This measure might boost ABS’s attractiveness to prospective purchasers. By acquiring complete control of De Novo, ABS acquires exclusive access to significant intellectual property, notably genetic developments. This represents them as a more self-sufficient and inventive organization, resulting in a better market value. Consequently, the dairy and beef segments may witness a change in emphasis, leading us to the next important question: will they keep, divest, or reform these sectors?

This purchase might simplify operations for the dairy sector and enable more consistent genetic improvements, aligning ABS with industry leaders such as STgen and URUS. A buyer interested in dairy genetics may view this as a chance to profit from ABS’s newly discovered capabilities.

The swine market may benefit from a targeted emphasis on genetic excellence. However, suppose reports regarding ABS’s divestment intentions are accurate. In that case, the future of the company’s swine operations might be wholly dependent on another firm. This might lead to specialist swine genetics businesses targeting Genus/PIC for purchase.

The more significant implications for the sector are compelling: an ABS focused on innovation and control may force rivals to boost their game. Dairy producers and experts may have access to cutting-edge genetic tools and increased herd performance. In contrast, selling the cattle and dairy divisions may generate new dynamics as various industry participants take over. In any case, the dairy and beef genetics landscape is likely to change significantly.

The Bottom Line

ABS’s ownership of De Novo resolves some of the conjectures regarding their future but still leaves many concerns unexplained. The purchase indicates a goal to consolidate intellectual property and reclaim control over product development, which might make them an intriguing acquisition target. ABS’s recent troubles and layoffs starkly contrast this investment, indicating a complicated, multifaceted approach. ABS’s efforts to establish a niche in a competitive field may signal either a new age of growth or a planned departure strategy. What are your thoughts?

Key Takeaways:

  • ABS Global’s acquisition of De Novo sparks speculations about its financial status and possible sale.
  • Market rumors suggest ABS is focused on its swine operations and may sell off its beef and dairy segments.
  • Potential buyers like URUS and STgen could be strategic fits for ABS’s dairy and beef sectors.
  • Acquiring De Novo gives ABS greater control over its product development, possibly making it more appealing to investors.
  • The move aligns ABS with the industry trend of owning and developing proprietary female programs.
  • ABS has experienced a market position decline since the ’90s; this acquisition could be a step toward regaining some lost ground.

Summary:

In the ever-evolving world of agribusiness, ABS Global’s recent acquisition of De Novo raises eyebrows and sparks intense speculation. This move comes on the heels of significant staffing layoffs and leads many to question the company’s financial health and strategic direction. Are they broke and desperate, or is this a calculated move to make the company more attractive for sale? Rumors swirl that Genus, ABS Global’s parent company, may be preparing for a significant deal with Chinese buyers, specifically interested in Genus’s intellectual property related to swine operations. On the other hand, giants like URUS and STgen could be positioning themselves to acquire ABS’s beef and dairy segments, adding even more intrigue to the unfolding drama. When it comes to agricultural markets, strategic acquisitions often signal deeper intentions and future transformations in market dynamics. The timing and circumstances of the transaction raise several questions, including whether ABS is consolidating intellectual property, preparing for market strategy shifts, and presenting all assets in a clean package. ABS, a subsidiary of Genus PLC, known for its diverse interests in swine genetics and biotechnology, aims to enhance pig production efficiency, attracting China’s interest due to its need for cost-effective protein production. This acquisition could make ABS more appealing to prospective buyers or align it more closely with Genus’ swine-focused objectives.

Learn more:

Join the Revolution!

Bullvine Daily is your essential e-zine for staying ahead in the dairy industry. With over 30,000 subscribers, we bring you the week’s top news, helping you manage tasks efficiently. Stay informed about milk production, tech adoption, and more, so you can concentrate on your dairy operations. 

NewsSubscribe
First
Last
Consent
Send this to a friend